Claim · model-written summary
Tebuconazole 2% Ds at 0.2% gave the minimum stripe disease incidence of 7.42% in barley.
- Taxon
- barley
Hordeum vulgaret0 - Treatment
- tebuconazole 2% Ds @ 0.2 %e0
- Interactor
- Drechslera graminea
Pyrenophora gramineat0pathogen - Outcome
- disease incidencee0
- Direction
- minimume0
- Value
- 7.42%e0
Not reportedMaterialGeneCompoundOrgan / stageSecond interactorSecond interactor roleComparatorSettingQualifier
Organisms pictured · Representative pictures of the matched species, not figures from the paper.
.jpg?width=500)

Verbatim
e0“tebuconazole 2% Ds @ 0.2 % was found best with minimum disease incidence (7.42%)”
t0“barley caused by Drechslera graminea”
Title
Virendra Kumar; PS Shekhawat; HR Kanwar Journal of Pharmacognosy and Phytochemistry 2019
Other claims from this paper (13)
- Intervention effect Tebuconazole 2% Ds at 0.2% gave the maximum barley grain yield of 55.01q.
- Intervention effect Tebuconazole 2% Ds at 0.2% gave the maximum barley fodder yield of 65.67q.
- Intervention effect Carboxin plus thiram seed treatment had 10.37% stripe disease incidence in barley.
- Intervention effect Carboxin plus thiram seed treatment produced barley grain yield of 52.66.
- Intervention effect Carboxin plus thiram seed treatment produced barley fodder yield of 62.65.
- Intervention effect Tebuconazole 2% Ds at 0.1% had 11.53% stripe disease incidence in barley.
- Intervention effect Tebuconazole 2% Ds at 0.1% produced barley grain yield of 51.29.
- Intervention effect Tebuconazole 2% Ds at 0.1% produced barley fodder yield of 61.59.
- Intervention effect Biological seed dressers were less effective than chemicals against barley stripe disease.
- Intervention effect Trichoderma viride performed well relative to other biological agents against barley stripe disease.
- Intervention effect T. harzianum performed well relative to other biological agents against barley stripe disease.
- Intervention effect Tebuconazole 2% Ds at 0.2% had the maximum cost benefit ratio of 1:2.63.
- Intervention effect Carboxin plus thiram at 0.2% had a cost benefit ratio of 1:2.53, following the best treatment.